Clinical Effects of New Approach on Patients With Non-alcoholic Steatohepatitis
NCT06105060
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
175
Enrollment
OTHER
Sponsor class
Conditions
Non-alcoholic Steatohepatitis
Interventions
DRUG:
Rosuvastatin 20mg
Sponsor
Beni-Suef University